GlassScriptPhysician profile
Brittany N Cox
NPI 1992027965
$5,009.82
in general payments reported to CMS, 2019-2025
35 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $394 · 2023: $481 · 2024: $2,734 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635 · Travel and Lodging: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,635.01 |
| Travel and Lodging | $856.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,143.61 | 2024-2025 | Clinical Trial Product |
| Abbvie INC. | $560.88 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $393.31 | 2023-2024 | Ingrezza, Ongentys |
| Acadia Pharmaceuticals INC | $301.64 | 2024-2025 | Nuplazid |
| Abiomed | $257.21 | 2024-2025 | Impella |
| Novo Nordisk INC | $249.97 | 2022-2025 | Ozempic |
| Organogenesis INC. | $232.59 | 2023-2024 | Puraply |
| Depuy Synthes Sales INC. | $181.34 | 2025 | Trumatch, Matrixneuro |
| Amneal Pharmaceuticals LLC | $139.98 | 2024-2025 | Ongentys, Rytary |
| Amgen INC. | $125.00 | 2024 | Evenity |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Aimmune Therapeutics, INC. | $123.63 | 2024 | |
| Microvention, INC. | $123.00 | 2023 | Web Aneurysm Embolization System, Stent, Hydrosoft Advanced |
| Eisai INC. | $122.06 | 2025 | |
| Neurelis, INC. | $119.89 | 2022-2024 | Valtoco |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $91.56 | 2023-2025 | Rystiggo, Briviact, Nayzilam |
| Sk Life Science, INC. | $86.20 | 2024-2025 | |
| Medtronic, INC. | $62.90 | 2024-2025 | Onyx 18, Intellis Adaptivestim |
| Csl Behring | $53.73 | 2023-2025 | Kcentra, Hizentra |
| Tg Therapeutics, INC. | $52.30 | 2024 | |
| Octapharma USA, INC. | $52.16 | 2024 | Panzyga |
| Baxter Healthcare | $48.97 | 2023 | Hillrom - Life 2000 Ventilation System |
| Esperion Therapeutics, INC. | $48.75 | 2022 | |
| Lundbeck LLC | $35.42 | 2024-2025 | Rexulti |
| Catalyst Pharmaceuticals, INC. | $34.93 | 2025 | |
| Alexion Pharmaceuticals, INC. | $33.17 | 2024 | Ultomiris |
| Janssen Biotech, INC. | $32.80 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $32.05 | 2024 | Austedo Xr |
| Caris Mpi, INC. | $26.58 | 2025 | Mi Cancer Seek |
| Tanabe Pharma America, INC. | $26.09 | 2024 | |
| Piramal Critical Care | $23.82 | 2024 | |
| Biogen, INC. | $21.50 | 2025 | Tysabri, Vumerity |
| Novocure INC. | $17.21 | 2025 | Optune Gio |
| Stryker Corporation | $16.81 | 2025 | Universal Neuro 3, Na |
| Otsuka America Pharmaceutical, INC. | $13.76 | 2024 | Nuedexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.